New asthma drug shows promise in early human trials
Symptom relief
Recruiting now
This study tests a new drug called PRA-216 in two phases. First, healthy volunteers receive single or multiple doses to check safety. Then, people with mild-to-moderate asthma receive the drug to see if it reduces airway inflammation and improves asthma control. The goal is to fi…
Phase: PHASE1, PHASE2 • Sponsor: Prana Therapies Inc • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC